Altitude Life Science Ventures targets $125 mln for third fund
Altitude Life Science Ventures is seeking to raise $125 million for its third fund, according to an SEC filing. The Kirkland, Washington-based venture firm invests in early-stage life science companies.
20 March 2018•1 min read
